Streetbeat News

Price Targets

SNA

Tigress Financial analyst Ivan Feinseth reiterates a Buy rating on Snap-on (SNA) and maintains a $336 price target.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:45 pm

XOMA

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on XOMA (NASDAQ:XOMA) and maintains a $74 price target.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:41 pm

IR

CFRA analyst Jonathan Sakraida has maintained a Hold rating on Ingersoll Rand (NYSE:IR) and increased the price target from $68 to $85.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:38 pm

SRPT

Needham analyst Gil Blum maintains a Buy rating on Sarepta Therapeutics (NASDAQ:SRPT) and raises the price target from $140 to $169.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:36 pm

DASH

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on DoorDash (NASDAQ:DASH) while raising the price target from $109 to $122.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:28 pm

COIN

Coinbase Global Inc (NASDAQ:COIN) received positive analyst ratings following its Q4 earnings beat, with revenue of $953.8 million and EPS of $0.51, surpassing expectations. Analysts highlighted Coinbase's thriving business amid increased volatility, trading volumes, and partnerships, particularly noting its role as custodian for 8 of the 11 approved spot BTC ETFs. Price targets were raised by several analysts, reflecting optimism about Coinbase's market leadership, expansion, and product initiatives. However, Goldman Sachs maintained a Sell rating despite raising its price target, citing market conditions as primary performance drivers.

Portfolio Pulse from Anusuya Lahiri

February 16, 2024 | 6:15 pm

NSIT

Barrington Research analyst Vincent Colicchio has maintained an Outperform rating on Insight Enterprises (NSIT) and raised the price target from $184 to $211.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:12 pm

PHAT

Needham analyst Joseph Stringer has reiterated a Buy rating on Phathom Pharmaceuticals (NASDAQ:PHAT) and maintained a $26 price target.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:10 pm

COIN

HC Wainwright & Co. analyst Mike Colonnese maintains a Buy rating on Coinbase Global (COIN) and raises the price target from $115 to $250.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:08 pm

STAG

RBC Capital analyst Michael Carroll has maintained a 'Sector Perform' rating on Stag Industrial (NYSE:STAG) and increased the price target from $39 to $40.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 6:02 pm